Cargando…

[(123)I]FP-CIT ENC-DAT normal database: the impact of the reconstruction and quantification methods

BACKGROUND: [(123)I]FP-CIT is a well-established radiotracer for the diagnosis of dopaminergic degenerative disorders. The European Normal Control Database of DaTSCAN (ENC-DAT) of healthy controls has provided age and gender-specific reference values for the [(123)I]FP-CIT specific binding ratio (SB...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tossici-Bolt, Livia, Dickson, John C., Sera, Terez, Booij, Jan, Asenbaun-Nan, Susanne, Bagnara, Maria C., Borght, Thierry Vander, Jonsson, Cathrine, de Nijs, Robin, Hesse, Swen, Koulibaly, Pierre M., Akdemir, Umit O., Koole, Michel, Tatsch, Klaus, Varrone, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5272851/ https://www.ncbi.nlm.nih.gov/pubmed/28130765 http://dx.doi.org/10.1186/s40658-017-0175-6

Ejemplares similares

The impact of reconstruction and scanner characterisation on the diagnostic capability of a normal database for [(123)I]FP-CIT SPECT imaging
por: Dickson, John C., et al.
Publicado: (2017)

No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [(123)I]FP-CIT (DaTSCAN) and SPECT
por: Thomsen, Gerda, et al.
Publicado: (2013)

Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An (123)I-FP-CIT SPECT study
por: Joling, Merijn, et al.
Publicado: (2019)

Imaging of serotonin transporters with [(123)I]FP-CIT SPECT in the human hypothalamus
por: Borgers, Anke J, et al.
Publicado: (2013)

Radioiodination and Purification of [(131)I]β-CIT and [(131)I]FP-CIT with an Automated Radiosynthesizer
por: Plhak, Elisabeth, et al.
Publicado: (2022)

((123)I)FP-CIT SPECT in suspected dementia with Lewy bodies: a longitudinal case study
por: Siepel, Françoise J, et al.
Publicado: (2013)

Serotonergic deficits in dementia with Lewy bodies with concomitant Alzheimer's disease pathology: An (123)I-FP-CIT SPECT study
por: van der Zande, J.J., et al.
Publicado: (2019)

Clinicopathological and (123)I‐FP‐CIT SPECT correlations in patients with dementia
por: Jung, Youngsin, et al.
Publicado: (2018)

Focal (123)I-FP-CIT SPECT Abnormality in Midbrain Vascular Parkinsonism
por: Solla, Paolo, et al.
Publicado: (2015)

Autopsy validation of (123)I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB
por: Thomas, Alan J., et al.
Publicado: (2017)

Evolution of clinical features in possible DLB depending on FP-CIT SPECT result
por: Walker, Zuzana, et al.
Publicado: (2016)

Japanese multicenter database of healthy controls for [(123)I]FP-CIT SPECT
por: Matsuda, Hiroshi, et al.
Publicado: (2018)

[(123)]FP-CIT SPECT scans initially rated as normal became abnormal over time in patients with probable dementia with Lewy bodies
por: van der Zande, J. J., et al.
Publicado: (2016)

A systematic review of the potential effects of medications and drugs of abuse on dopamine transporter imaging using [(123)I]I-FP-CIT SPECT in routine practice
por: Chahid, Youssef, et al.
Publicado: (2023)

Dopamine transporter imaging with [(18)F]FE-PE2I PET and [(123)I]FP-CIT SPECT—a clinical comparison
por: Jakobson Mo, Susanna, et al.
Publicado: (2018)

Positive FP-CIT SPECT (DaTSCAN) in Clinical Alzheimer's Disease – An Unexpected Finding?
por: Bittner, Verena, et al.
Publicado: (2011)

Computer-aided diagnosis for ((123)I)FP-CIT imaging: impact on clinical reporting
por: Taylor, Jonathan Christopher, et al.
Publicado: (2018)

Extrastriatal (123)I-FP-CIT SPECT impairment in Parkinson’s disease – the PPMI cohort
por: Nicastro, Nicolas, et al.
Publicado: (2020)

Diagnostic accuracy of (18)F-FP-CIT PET for clinically uncertain Parkinsonian syndrome
por: Oh, Minyoung, et al.
Publicado: (2023)

Bipolar Disorder and Parkinson disease: a 123I-FP-CIT SPECT study
por: D’agostino, G., et al.
Publicado: (2023)

Lower (123)I-FP-CIT binding to the striatal dopamine transporter, but not to the extrastriatal serotonin transporter, in Parkinson's disease compared with dementia with Lewy bodies
por: Joling, Merijn, et al.
Publicado: (2018)

Clinical evaluation of [(123)I]FP-CIT SPECT scans on the novel brain-dedicated InSPira HD SPECT system: a head-to-head comparison
por: Adriaanse, Sofie M., et al.
Publicado: (2018)

Effects of l-DOPA on striatal iodine-123-FP-CIT binding and behavioral parameters in the rat
por: Nikolaus, Susanne, et al.
Publicado: (2013)

Case Report: Bupropion Reduces the [(123)I]FP-CIT Binding to Striatal Dopamine Transporter
por: Milenkovic, Ivan, et al.
Publicado: (2021)

Diagnostic value of micrographia in Parkinson’s disease: a study with [(123)I]FP-CIT SPECT
por: Eklund, Mikael, et al.
Publicado: (2022)

Multi-Atlas MRI-Based Striatum Segmentation for (123)I-FP-CIT SPECT (DAT-SPECT) Compared With the Bolt Method and SPECT-Atlas-Based Segmentation Method Toward the Accurate Diagnosis of Parkinson's Disease/Syndrome
por: Sohara, Koji, et al.
Publicado: (2021)

1983 Cryogenic Engineering Conference
por: Fast, R W
Publicado: (1984)

Differential Diagnosis of Patients with Inconclusive Parkinsonian Features Using [(18)F]FP-CIT PET/CT
por: Park, Eunkyung, et al.
Publicado: (2013)

F-18 FP-CIT PET in Multiple System Atrophy of the Cerebellar Type: Additional Role in Treatment
por: Jeong, Young Jin, et al.
Publicado: (2017)

18F-FP-CIT Positron Emission Tomography for Correlating Motor and Cognitive Symptoms of Parkinson's Disease
por: Yang, YoungSoon, et al.
Publicado: (2017)

Count-based method for specific binding ratio calculation in [I-123]FP-CIT SPECT analysis
por: Rahman, Mahmudur G. M., et al.
Publicado: (2018)

A Novel Automatic Approach for Calculation of the Specific Binding Ratio in [I-123]FP-CIT SPECT
por: Rahman, Mahmudur G. M., et al.
Publicado: (2020)

(123)I-FP-CIT SPECT validation of nigro-putaminal MRI tractography in dementia with Lewy bodies
por: Pardini, Matteo, et al.
Publicado: (2020)

Early-phase (18)F-FP-CIT and (18)F-flutemetamol PET were significantly correlated
por: An, Young-Sil, et al.
Publicado: (2021)

Salivary Gland Uptake on (18)F-FP-CIT PET as a New Biomarker in Patients With Parkinsonism
por: Kang, Seo Young, et al.
Publicado: (2023)

Reliability of visual assessment by non-expert nuclear medicine physicians and appropriateness of indications of [(123)I]FP-CIT SPECT imaging by neurologists in patients with early drug-naive Parkinson’s disease
por: Suwijn, Sven R., et al.
Publicado: (2019)

(123)I-FP-CIT SPECT imaging in early diagnosis of dementia in patients with and without a vascular component
por: Garriga, Marina, et al.
Publicado: (2015)

Optimal ROI setting on the anatomically normalized I-123 FP-CIT images using high-resolution SPECT
por: Nonokuma, Masanari, et al.
Publicado: (2016)

Serial I-123-FP-CIT SPECT Image Findings of Parkinson's Disease Patients With Levodopa-Induced Dyskinesia
por: Jeong, Eun Hye, et al.
Publicado: (2018)

Classification of degenerative parkinsonism subtypes by support-vector-machine analysis and striatal (123)I-FP-CIT indices
por: Nicastro, Nicolas, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tp3nvgb49mucpk1o97h38u983s